Dr. Waheeda Nazneen, MD

Dr. Nazneen practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Nazneen's NPI, 1124237532, was assigned on May 22, 2007. Dr. Nazneen holds Michigan license 4301086173.

Dr. Nazneen's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Nazneen's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Nazneen is also affiliated with Henry Ford Hospital. The medical group on file is Critical Care & Pulmonary Consultants. Dmand AI also links Dr. Nazneen to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nazneen practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Nazneen's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Nazneen is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Nazneen is licensed in Michigan.

CMS data shows 1,422 Medicare services from Dr. Nazneen across 16 procedure codes in 2024, for 421 Medicare patients. Medicare paid $111,677 for them.

CMS counts 421 Medicare patients who saw Dr. Nazneen in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 3.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nazneen's median patient age at 72, with 63% women.

In 2024, Dr. Nazneen wrote 1,704 Medicare Part D claims for 209 patients. 41% of them were for generic drugs. CMS names the drug for 1,536 of them, across 31 drugs with 11 or more claims each, at $1,728,274 in total drug cost. In 2023, CMS named 1,182 claims across 27 drugs.

Dr. Nazneen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nazneen as offering telehealth.

CMS Open Payments shows 216 general payments to Dr. Nazneen from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $661.